Bangladesh-based Square Pharmaceuticals has two new plants online

A Square facility--Courtesy of Telstar

Spain design and build firm Telstar says it has completed the two newest manufacturing plants for Square Pharmaceuticals, the largest drugmaker in Bangladesh. The project included a 32,000-square-meter, four-story solid-dose facility that included 11 tablet lines and four capsule lines. The second is a 20,000-square-meter, four-story building for producing parenterals to be packaged in bags, vials, prefilled syringes and lyophilized vials. Square said in June that the FDA had passed its manufacturing facilities in a preproduction audit. Release | More

Suggested Articles

Gilead expects to sell 1 million to 1.5 million treatment courses of remdesivir in 2020. That means about $3.5 billion in sales, one analsyt figures.

Pfizer and BioNTech followed supply pacts in the U.S. and U.K. with a new deal to deliver 120 million vaccines to Japan in the first half of 2021.

Warp Speed's largest outlay to date, the funding will cover development and manufacturing scale-up of a vaccine that uses proven Sanofi technology.